Sep 07, 2021 05:07 PM (GMT+8) · EqualOcean
Cailian, September 7 (Reuters) - HongRi pharmaceutical announced that the company received a notice from Zheng Dan and LAN Wujun, directors of the company, and Chen Ruiqiang, Zhang Kun and Li Chunxu, deputy general managers of the company today. The above personnel reduced a total of 2330000 shares of the company through the block trading system of Shenzhen Stock Exchange on September 6, 2021, accounting for 0.0776% of the total share capital of the company.
Related companies: